Commentary
Video
Factors Influencing Personalized Parkinson Disease Care
Author(s):
Stuart H. Isaacson, MD, FAAN, speaks to the current understanding of genetics and other factors in the individualization of care for patients with Parkinson disease.
Video Player is loading.
Editor's note: Because of an unfortunately unaddressable issue, the audio for this episode may be slightly distorted at times. Please see the transcript below for clarity.
Transcript to come.
Related Videos
Patients’ Experience With Foscarbidopa/Foslevodopa CSCI for Treatment of Parkinson Disease
Tailoring Precision Medicine Treatment of Hemorrhagic Stroke Through Predictive Models: Kara R. Melmed, MD
Clinical Data With Foscarbidopa/Foslevodopa CSCI in Parkinson Disease
Optimizing Benzodiazepine Use for Breakthrough Seizures in Epilepsy
Enhancing Brain Plasticity by Personalized and Closed-Loop Neuromodulation: Roy H. Hamilton, MD, MS, FAAN
Setting Realistic Goals for Long-Standing Spinal Muscular Atrophy
Efgartigimod for CIDP in Clinical Practice
Transitioning Patients From IVIg to Efgartigimod
Evolving Evidence and Clinical Confidence for Blood Pressure Management in Intracerebral Hemorrhage: Chitra Venkatasubramanian, MBBS, MD, MSc, FNCS
Starting Treatment in SMA: What Clinicians Need to Consider
Related Content
